1. Home
  2. ISTR vs LCTX Comparison

ISTR vs LCTX Comparison

Compare ISTR & LCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ISTR
  • LCTX
  • Stock Information
  • Founded
  • ISTR 2006
  • LCTX 1990
  • Country
  • ISTR United States
  • LCTX United States
  • Employees
  • ISTR N/A
  • LCTX N/A
  • Industry
  • ISTR Major Banks
  • LCTX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • ISTR Finance
  • LCTX Health Care
  • Exchange
  • ISTR Nasdaq
  • LCTX Nasdaq
  • Market Cap
  • ISTR 189.6M
  • LCTX 107.3M
  • IPO Year
  • ISTR 2014
  • LCTX N/A
  • Fundamental
  • Price
  • ISTR $21.82
  • LCTX $1.01
  • Analyst Decision
  • ISTR Buy
  • LCTX Strong Buy
  • Analyst Count
  • ISTR 1
  • LCTX 5
  • Target Price
  • ISTR $27.00
  • LCTX $4.20
  • AVG Volume (30 Days)
  • ISTR 39.7K
  • LCTX 4.5M
  • Earning Date
  • ISTR 07-21-2025
  • LCTX 08-07-2025
  • Dividend Yield
  • ISTR 1.92%
  • LCTX N/A
  • EPS Growth
  • ISTR 22.25
  • LCTX N/A
  • EPS
  • ISTR 2.19
  • LCTX N/A
  • Revenue
  • ISTR $88,885,000.00
  • LCTX $9,557,000.00
  • Revenue This Year
  • ISTR $2.04
  • LCTX N/A
  • Revenue Next Year
  • ISTR $9.79
  • LCTX $232.66
  • P/E Ratio
  • ISTR $9.99
  • LCTX N/A
  • Revenue Growth
  • ISTR 6.35
  • LCTX 19.42
  • 52 Week Low
  • ISTR $14.91
  • LCTX $0.37
  • 52 Week High
  • ISTR $24.81
  • LCTX $1.15
  • Technical
  • Relative Strength Index (RSI)
  • ISTR 72.03
  • LCTX 67.32
  • Support Level
  • ISTR $19.17
  • LCTX $0.85
  • Resistance Level
  • ISTR $19.34
  • LCTX $1.15
  • Average True Range (ATR)
  • ISTR 0.70
  • LCTX 0.12
  • MACD
  • ISTR 0.27
  • LCTX -0.00
  • Stochastic Oscillator
  • ISTR 95.97
  • LCTX 70.83

About ISTR Investar Holding Corporation

Investar Holding Corp is a U.S.-based financial holding company. Through its subsidiaries, it offers a variety of commercial and retail lending products throughout its market areas, including business loans to small to medium-sized businesses, as well as loans to individuals. It has business operations spread across the United States and serves its customers through several service branches. The bank also offers cashiers' checks, direct deposit of payroll and Social Security checks, night depository, bank-by-mail, automated teller machines with deposit automation, and debit cards.

About LCTX Lineage Cell Therapeutics Inc.

Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline is based on two platform technologies including cell replacement and cell/drug delivery. Lineage Cell's product candidate is OpRegen, a retinal pigment epithelium transplant therapy for the treatment of dry age-related macular degeneration, OPC1, an oligodendrocyte progenitor cell therapy for acute spinal cord injuries, and VAC2, allogeneic cancer immunotherapy of antigen-presenting dendritic cells for non-small cell lung cancer, ANP1, an allogeneic auditory neuron progenitor cells transplant for hearing loss, and PNC1, an allogeneic photoreceptor cell transplant for vision loss.

Share on Social Networks: